David Lager

In a note released on Thursday, Oppenheimer said it is reinstating an Outperform rating on Humana Inc (NYSE: HUM), attributing the move to the termination of the company's merger with Aetna Inc (NYSE: AET). The firm has a 12–18-month price target of $236 for the company. The firm presented...